Apixio Fact Sheet Delivering Actionable Insights from Textual, Scanned and Coded Data for Optimal Risk Assessment Apixio was founded in 2009 to transform how providers and healthcare organizations access, analyze, and use clinical data for optimal care. Its premier product is the Apixio HCC Optimizer, a smart coding application with automated extraction and analysis of clinical text and a lower cost for Medicare Advantage (MA) and individual/ small group plan members. Apixio’s HCC Optimizer Value Increases Revenue • Proven $80 to $150 per patient per analysis (even after coding has already been completed). HCC Optimizer presents chronic conditions not previously coded (“HCC coding opportunities”) for rapid review and approval using a web-based application. Decreases Costs • Manual patient chart extraction costs are eliminated. Apixio’s Big Data platform pulls clinical text, scanned data, and claims data directly from source systems (including EHR systems such as Epic and Allscripts) using a fully automated and scalable data pipeline. Improves Productivity • Coders review charts 30 to 40 times faster than manual chart audit. HCC Optimizer uses Apixio’s proprietary machine-learning algorithms to review all patient textual data to identify only those encounter documents with HCC coding opportunities for review. Case Study #1 - Large Delegated Provider Group • • • • • • MA Lives: 19,531 Chart Review: 2nd pass for January 2013 sweep* EMR Integration: NextGen Revenue Increase: $1.3 million Total ROI : 8.6 to 1 Delegated Provider ROI: 6.5 to 1 *100% chart audit had already been completed Case Study #2 - Health Plan • • • • • MA Lives: 7,500 Chart Review: 1st pass for Sept. 2013 sweep EMR Integration: NextGen Revenue Increase: $1.4 million Client ROI: 6.7 to 1 Executive Management Team Darren Schulte, MD, MPP, Chief Executive Officer Bob Rogers, PhD, Chief Scientist Ownership Apixio is privately owned. Company Headquarters 1825 South Grant Street, Suite 210 San Mateo, CA 94402 877.427.4946 www.apixio.com